Home - Boston Life Sciences Times

LATEST ARTICLES

Medtech

Establishment Labs Submits Motiva Implants to FDA for Breast Reconstruction Approval

Life Sciences Times - December 29, 20250

Venture Capital

Johnson & Johnson Completes Acquisition of Halda Therapeutics

Life Sciences Times - December 29, 20250

Pharma

QurAlis Reports Early Clinical Evidence of Target Engagement for QRL-101 in ALS Patients

Life Sciences Times - December 29, 20250

Biotech

Enveric Biosciences Announces Issuance of New U.S. Patent

Life Sciences Times - December 29, 20250

Biotech

Modalis Reports Publication Showing Promising Gene Activation Approach for LAMA2-CMD

Life Sciences Times - December 29, 20250

People on the Move

PharmaEssentia USA Appoints Jeffrey Williams as Independent Director

Life Sciences Times - December 29, 20250

People on the Move

instED Names Don Stiffler Chief Executive Officer

Life Sciences Times - December 29, 20250

Medtech

FDA Approves Edwards Lifesciences’ SAPIEN M3 as First Transseptal Transcatheter Mitral Valve Replacement

Life Sciences Times - December 23, 20250

Medtech

RevBio Receives FDA Clearance to Launch Dental Clinical Trial for Regenerative Bone Glue

Life Sciences Times - December 23, 20250

Biotech

Enveda Advances Third Drug Candidate Into Clinic With FDA Clearance for ENV-6946

Life Sciences Times - December 23, 20250

1...555657...831 Page 56 of 831

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

May 1, 2026

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

May 1, 2026

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

May 1, 2026

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Most Popular

Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Recent Comments

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study

SK Capital Completes Sale of Noramco Group Businesses to Siegfried

POPULAR CATEGORY

ABOUT US

FOLLOW US